China has stated that they could have a COVID-19 vaccine developed by November.
An official with the Chinese Center for Disease Control and Prevention (CDC) told Reuters that the vaccine could be available for the general public at the end of the year.
China’s CDC biosafety expert, Guizhen Wu, confirmed the news in an interview on Wednesday last week.
She also said she took her experimental COVID vaccine in April and did not face any abnormal symptoms. However, she did not specify what vaccine she took.
Four vaccine candidates in China
China, from where COVID-19 emerged, has four COVID-19 vaccine candidates that are in the final trials of their phase.
According to Reuters, essential workers have at least three of these for emergency use program, which was started in July.
There are over 300 COVID-19 vaccine candidates in development in various countries across the world.
So far, COVID-19 has killed over 925,000 people, while infected a further 29.1 million.
Science above politics
With each emerging trend, scientists pledged to follow through with the scientific method of developing the vaccine. They would not bow to political pressure.
This comes after Russian President, Vladimir Putin, announced that the Sputnik-2, a COVID vaccine in development in Russia, was ready for the public. However, essential workers in the country refused to get their shots.
The Sputnik has come under critical lenses, with many health experts expressing reservations about it.
A COVID vaccine could allow for life to go back to a semblance of normalcy. However, that will take a while, according to experts.
US infectious disease experts, Dr Anthony Fauci, said that we could practice social distancing in the near future even after the vaccine is publicly available.
This he said, was due to the fact that the vaccine could be only 50-60% effective in the initial stages. Furthermore, the vaccine may not be widely available for everyone in the first few months.